DR
Alpha Tau Medical Ltd.
DRTSW · NASDAQ
$4.29 -0.92% (-$0.04)
1M +9.25%
Market Cap $376.2M
P/E Ratio -
Div. Yield -
ROE 138.12%
Bulios Fair Price
$2.86
33.3% downside
Current Price
$4.29
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DRTSW is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 8.54x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 9.97%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 40.12%
ROE 138.12%
ROA 68.96%
Debt
67 /100
Low Debt/Equity 0.34x
Current ratio 11.09x
Int. coverage -1.16x
Stability
62 /100
Moderate Beta 1.19x
EPS volatility 19.90%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DRTSW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Uzi Sofer
Employees
112
Headquarters
Jerusalem
Upcoming events
24 NOV
Earnings
Upcoming earnings report